Pfizer Covid-19 vaccine shows 90.7% efficacy in 5 to 11 year olds

Pfizer's Covid-19 vaccine was 90.7% effective in 5 to 11 year olds in clinical trials, according to new FDA documents. CNBC's Meg Tirrell reports.